A detailed history of Squarepoint Ops LLC transactions in Medicinova Inc stock. As of the latest transaction made, Squarepoint Ops LLC holds 14,856 shares of MNOV stock, worth $20,798. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,856
Previous 15,150 1.94%
Holding current value
$20,798
Previous $22,000 4.55%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.28 - $1.65 $376 - $485
-294 Reduced 1.94%
14,856 $21,000
Q4 2023

Feb 14, 2024

BUY
$1.38 - $2.06 $466 - $696
338 Added 2.28%
15,150 $22,000
Q2 2023

Aug 14, 2023

SELL
$2.09 - $2.43 $3,856 - $4,483
-1,845 Reduced 11.08%
14,812 $34,000
Q1 2023

May 15, 2023

SELL
$1.95 - $2.54 $4,069 - $5,300
-2,087 Reduced 11.13%
16,657 $35,000
Q4 2022

Feb 14, 2023

BUY
$1.97 - $2.66 $36,925 - $49,859
18,744 New
18,744 $38,000
Q3 2021

Nov 15, 2021

SELL
$3.4 - $4.24 $96,913 - $120,856
-28,504 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$3.76 - $5.14 $107,175 - $146,510
28,504 New
28,504 $121,000
Q3 2020

Nov 16, 2020

SELL
$4.67 - $11.0 $48,908 - $115,203
-10,473 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$3.06 - $7.06 $32,047 - $73,939
10,473 New
10,473 $57,000
Q1 2020

May 15, 2020

SELL
$2.9 - $6.97 $120,048 - $288,530
-41,396 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$6.48 - $8.76 $71,027 - $96,018
10,961 Added 36.01%
41,396 $279,000
Q3 2019

Nov 14, 2019

BUY
$7.7 - $10.42 $71,094 - $96,207
9,233 Added 43.55%
30,435 $242,000
Q2 2019

Aug 14, 2019

BUY
$8.29 - $13.22 $59,969 - $95,633
7,234 Added 51.79%
21,202 $204,000
Q1 2019

May 15, 2019

BUY
$6.82 - $10.27 $95,261 - $143,451
13,968 New
13,968 $116,000
Q4 2018

Feb 14, 2019

SELL
$7.65 - $12.83 $107,100 - $179,620
-14,000 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$7.06 - $12.49 $98,840 - $174,860
14,000 New
14,000 $175,000

Others Institutions Holding MNOV

About MEDICINOVA INC


  • Ticker MNOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,046,200
  • Market Cap $68.7M
  • Description
  • MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...
More about MNOV
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.